In murine B16 melanoma, MC38 colon cancer, and human multiple myeloma cells, these bispecific antibodies significantly migrated into tumors, attracted by the presence of PD-L1 in tumor cells and by the secretion of Exo-PD-L1 [68]. Here, CD274 is linked to plasma cell myeloma.